Citations

Clear

2117 citation(s) found for "Mayo, Steven".

Assessment of Interrater Reliability for Interpretation of Musculoskeletal Ultrasound Imaging of the Quadriceps Femoris
McGurren, Daniel , Glattke, Kaycee , Poon, Steven K. , Brinkman, Joseph C. , Goetzinger, Sara, Lee, J A, Nocella, A, Rogge, Jeffrey, Luigi, Arthur Jason De , McGurren, Daniel P, Boddu, Sayi P. , Nocella, Alyssa, Chhabra, Anikar , Flug, Jonathan A. , Rogge, Jeffrey

Mayo Clinic

American Journal of Physical Medicine & Rehabilitation | March 18, 2025 | Volume: 104 | Issue: 10 | Pages: 906-910

10.1097/phm.0000000000002731 | PMID 40101801 Get It

Objective The aim of the study was to assess the interrater reliability between seven individuals assessing quadriceps femoris cross-sectional area, echo intensity, and corrected echo intensity. Design A retrospective subanalysis of data collected in a randomized controlled clinical trial (IRB 19-008473. NCT ID NCT04302558). Patients aged 13–50 yrs with an anterior cruciate ligament tear requiring surgical reconstruction were assessed for cross-sectional area of the rectus femoris, vastus intermedius, vastus lateralis, vastus medialis, and vastus medialis obliquis, and echo intensity of the rectus femoris. Musculoskeletal ultrasound imaging of the quadriceps was performed by one physical therapist, and quantitative assessments were performed by four physicians and three physical therapists. Results Physicians and physical therapists had good reliability for cross-sectional area of the rectus femoris (median interclass correlation 0.86 doctor of medicine (MD) and 0.84 physical therapist), cross-sectional area of the vastus medialis obliquis (0.82 and 0.82), and echo intensity mean (0.92 and 0.92). Rectus femoris cross-sectional area had the smallest coefficient of variation (26.512.7%), whereas subcutaneous fat had the largest coefficient of variation (93.3% left, 86.4% middle, 86.1% right). Conclusions These findings demonstrate reliability between physicians and physical therapists in interpretation of ultrasound images of the quadriceps. The inconsistency demonstrates the need for a consistent training across disciplines to ensure accurate image interpretation.
Development of an Undiagnosed Mass Registry: Lessons Learned From Our First 100 Patients
Ressler, Steven W. , Croghan, Ivana T. , Girardo, Marlene , Fasolino, John P., Gilman, Elizabeth A. , Erwin, Nate P., Dawson, Nancy L. , Irizarry-Alvarado, Joan M., Ghosh, Karthik, Hurt, Ryan T. , Gilman, Elizabeth A , Ressler, Steven W

Mayo Clinic

Journal of Primary Care & Community Health | March 13, 2025 | Volume: 16 | Issue: No issue available | Pages: No page available

10.1177/21501319251325650 | PMID 40080395 Get It

Introduction: The Undiagnosed Mass Clinic (UMC) at our institution is a clinical and research program created to address gaps in the early diagnostic phase of the cancer care continuum for patients with potential malignant neoplasms. All patients referred to the UMC are invited to participate in the UMC registry, which tracks operational and clinical metrics while maintaining a repository of blood and tissue specimens for future research. Methods: We conducted a retrospective cohort study of the first 100 patients enrolled in the UMC registry. We analyzed patient demographics, final diagnoses, and the time from initial consultation to final diagnosis. Results: Most participants were White (86%), non-Hispanic (93%), and married (72%). The mean (SD) age was 64 (13.9) years. The final diagnoses of the masses were categorized as malignant/neoplastic with malignant potential (n = 53), benign (n = 36), or requiring diagnostic surveillance (n = 10). The mean (SD) time from initial consultation to final diagnosis of malignant/neoplastic with malignant potential masses significantly improved from 37.4 (36.6) days for the first 50 participants to 17.3 (19.7) days for the next 50 participants ( P = .006). Conclusions: These initial insights from the UMC registry will help direct future efforts to improve the care of patients with potential malignant neoplasms.
Modulating limbic circuits in temporal lobe epilepsy: impacts on seizures, memory, mood and sleep
Křemen, Václav , Sladky, Vladimir , Mívalt, Filip , Gregg, Nicholas M. , Brinkmann, Benjamin H. , Balzekas, Irena , Marks, Victoria S. , Lundstrom, Brian N. , Cui, Jie, Alden, Eva , Fields, Julie A. , Crockett, Karla, Adolf, Jindřich , Bilderbeek, Jordan, Hermes, Dora, Miller, Kai J. , Bilderbeek, Jordan , Marks, Victoria S , Kucewicz, Michal, Lundstrom, Brian Nils , St Louis, E K , Croarkin, Paul E , Alden, Eva C, Messina, Steven, Miller, Kai Joshua, Van Gompel, Jamie, Brinkmann, Benjamin H , Kremen, Vaclav , Gregg, Nicholas M , Bilderbeek, Jordan A , Mivalt, Filip , Kucewicz, Michał T. , Cui, Jie , Louis, Erik K. St. , Croarkin, Paul E. , Joseph, Boney , Hermes, Dora , Messina, Steven A. , Gompel, Jamie J. Van , Denison, Timothy , Worrell, Gregory A.

Mayo Clinic

Brain Communications | March 7, 2025 | Volume: 7 | Issue: 2 | Pages: No page available

10.1093/braincomms/fcaf106 | PMID 40196395 Get It

Abstract Temporal lobe epilepsy is a common neurological disease characterized by recurrent seizures that often originate within limbic networks involving amygdala and hippocampus. The limbic network is involved in crucial physiologic functions involving memory, emotion and sleep. Temporal lobe epilepsy is frequently drug-resistant, and people often experience comorbidities related to memory, mood and sleep. Deep brain stimulation targeting the anterior nucleus of the thalamus (ANT-DBS) is an established therapy for temporal lobe epilepsy. However, the optimal stimulation parameters and their impact on memory, mood and sleep comorbidities remain unclear. We used an investigational brain sensing-stimulation implanted device to accurately track seizures, interictal epileptiform spikes (IES), and memory, mood and sleep comorbidities in five ambulatory subjects. Wireless streaming of limbic network local field potentials (LFPs) and subject behaviour were captured on a mobile device integrated with a cloud environment. Automated algorithms applied to the continuous LFPs were used to accurately cataloged seizures, IES and sleep-wake brain state. Memory and mood assessments were remotely administered to densely sample cognitive and behavioural response during ANT-DBS in ambulatory subjects living in their natural home environment. We evaluated the effect of continuous low-frequency and duty cycle high-frequency ANT-DBS on epileptiform activity and memory, mood and sleep comorbidities. Both low-frequency and high-frequency ANT-DBS paradigms reduced seizures. However, continuous low-frequency ANT-DBS showed greater reductions in IES, electrographic seizures and better sleep and memory outcomes. These results highlight the potential of synchronized brain sensing and dense behavioural tracking during ANT-DBS for optimizing neuromodulation therapy. While studies with larger patient numbers are needed to validate the benefits of low-frequency ANT-DBS, these findings are potentially translatable to individuals currently implanted with ANT-DBS systems.
Comparing Early Intervention to Watchful Waiting: A Review on Risk Stratification and Management in Asymptomatic Aortic Stenosis
Khedr, Ahmed E. , Odeh, Nour B., Bcharah, George , Abdalla, Hesham, Senjab, Abdulrahman , Zeineddine, Rawan M. , Ram, Jai, Farina, Juan M. , Crystal, Owen , Barrus, Bryan , Lester, Steven J., Shipman, Justin , Alsidawi, Said , Sell‐Dottin, Kristen , Arsanjani, Reza , Abdalla, Hesham M, Ram, Jaikrishnan, Crystal, Owen R, Sell-Dottin, Kristen A , Arsanjani, Reza , Farina, Juan M , Alsidawi, Said , Khedr, Ahmed , Ram, Jaikrishnan

Mayo Clinic

Medicina | March 4, 2025 | Volume: 61 | Issue: 3 | Pages: 448

10.3390/medicina61030448 | PMID 40142259 Get It

Aortic stenosis is a progressive condition with substantial implications for morbidity and mortality. In recent years, attention has shifted toward risk stratification and the development of individualized management plans to optimize treatment outcomes. The management of asymptomatic patients has become a topic of significant controversy, as emerging studies challenge traditional watchful waiting guidelines and propose the potential benefits of early intervention. While early intervention may reduce overall morbidity and mortality in this patient population, the associated procedural risks remain a critical consideration. This review seeks to analyze the existing literature, offering an updated perspective on patient risk stratification and evidence evaluating both management approaches.
Infrapatellar branch of saphenous nerve: from anatomy, sonoanatomy to its clinical implications
Peng, Michael SJ , Clendenen, Steven R. , Tsui, Ban C H , Clendenen, Steven R , Shi, Glenn G. , Tsui, Ban C. H.

Mayo Clinic

Regional Anesthesia & Pain Medicine | February 27, 2025 | Volume: 51 | Issue: 4 | Pages: 465-472

10.1136/rapm-2025-106383 | PMID 40015723 Get It

The infrapatellar branch of the saphenous nerve (IPBSN) is implicated in nerve injury from different knee surgeries because of its intimate course relative to the knee joint capsule. Pain physicians encounter patients in their practice for the management of neuralgia of this nerve or in the context of advanced management of knee osteoarthritis. This article aims to provide a comprehensive review of the anatomy, sonoanatomy, and the intervention of the IPBSN in pain management of infrapatellar neuralgia and chronic knee pain.
Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience
Hwang, Steven R. , Gysbers, Brianna J. , Mwangi, Raphael , Nedved, Adrienne, Barreto, Jason N. , Micallef, Ivana N. , Ansell, Stephen M. , Porrata, Luis F. , Thanarajasingam, Gita , Johnston, Patrick B., Khurana, Arushi , Gysbers, Brianna J , Nedved, Adrienne N, Barreto, Jason N , Micallef, Ivana N , Ansell, Stephen M , Porrata, Luis, Durani, Urshila , Thanarajasingam, Gita , Habermann, Thomas , Maurer, Matthew , Khurana, Arushi , Hwang, Steven R , Godby, Richard , Durani, Urshila , Habermann, Thomas M. , Maurer, Matthew J. , Johnston, Patrick B.

Mayo Clinic

Blood Advances | February 18, 2025 | Volume: 9 | Issue: 4 | Pages: 924-932

10.1182/bloodadvances.2024014073 | PMID 39964705 Get It

Abstract Primary central nervous system lymphoma (PCNSL) is a rare form of non-Hodgkin lymphoma involving the brain, cerebrospinal fluid, or retina/vitreous without systemic involvement. Induction with high-dose methotrexate (HD-MTX) followed by consolidation with autologous stem cell transplant (auto-SCT) has become the standard treatment paradigm for most patients. However, limited data are available regarding the efficacy of a maintenance approach with HD-MTX. Herein, we retrospectively reviewed the characteristics and outcomes of 148 patients diagnosed with PCNSL between October 2010 and June 2022, who underwent HD-MTX–based induction therapy followed by either auto-SCT consolidation (n = 70) or HD-MTX maintenance therapy (n = 37). At a median follow-up time of 4.5 years, the progression-free survival (PFS) was 8.3 years and the overall survival (OS) was not reached. Compared to patients who underwent auto-SCT, patients who received maintenance HD-MTX had a higher median age at diagnosis of 72 vs 62 years and a trend toward higher proportion of patients being Eastern Cooperative Oncology Group 2 or higher (41% vs 29%). At 5-years postinduction treatment initiation, the PFS rates in the auto-SCT cohort and HD-MTX maintenance cohort were 74.6% and 72.6%, respectively, and the OS rates were 76.0% and 82.4%, respectively. Overall, there was no significant difference in PFS or OS based on postinduction management strategy. Our data suggest that maintenance HD-MTX may be a reasonable, time-limited treatment strategy for patients with PCNSL responding to initial induction therapy.
Sangre Por Salud (SPS) Biobank: cohort profile
Zarrugh, Emmil, Girardo, Marlene , Ryu, Euijung , Garzon, Giovanna Moreno, Hernandez, Valentina, Levey, Sharon, Gonzalez, Crystal, Pompa, Daniela B, Sharp, Richard R. , Mandarino, Lawrence J. , Thibodeau, Steven, Filippis, Eleanna De , Bielinski, Suzette , Moreno Garzon, Giovanna, Meagher, Karen, De Filippis, Eleanna , Sharp, Richard R , Bielinski, Suzette J. , Garzon, Giovanna G. Moreno, Singh, Davinder , Meagher, Karen M. , Shaibi, Gabriel Q. , Cerhan, James R. , Olson, Janet E.

Mayo Clinic

BMJ Open | February 11, 2025 | Volume: 15 | Issue: 2 | Pages: e093445

10.1136/bmjopen-2024-093445 | PMID 39933806 Get It

Purpose The Sangre Por Salud (SPS) Biobank was established to facilitate biomedical research opportunities for the Latino community by creating an easily accessible prospective cohort for scientists interested in studying health conditions and health disparities in this population. Participants Individuals self-identifying as Latino, aged 18–85 years, were prospectively recruited from the primary care Internal Medicine clinic at Mountain Park Health Center in Phoenix, Arizona. After obtaining informed consent, detailed medical history questionnaires were captured, and blood samples were obtained for common laboratory tests. Participants authorised the research team to access their electronic health records for research purposes. In addition, participants had serum, plasma and DNA samples isolated and stored at the Mayo Clinic Arizona Biorepository Laboratory for long-term storage and future access. As part of the study, participants consented and agreed to be contacted for potential participation in future research studies. Findings to date 3756 participants provided informed consent, of whom 3733 completed all study questionnaires, an oral glucose tolerance test and had blood collected and stored. The SPS cohort is predominantly composed of females (72%), with a median age at time of consent of 42 years. All participants self-identified as Hispanic/Latino, 45% were married, 53% were employed for wages and 60% had less than a high school degree. Around 25% of participants met diagnostic criteria for overweight (BMI 25–29 kg/m 2 ), and 49% met for obesity (BMI≥30 kg/m 2 ). At time of recruitment, hypertension, hyperlipidaemia and depression affected 22%, 20% and 13% of the cohort, respectively. Future plans We plan to regularly update the participants’ electronic health records and self-reported health data to longitudinal research. Additionally, we plan to obtain a more comprehensive genomic analysis on the entire cohort, ensuring greater research interest and investigation into the underlying genetic factors that contribute to disease susceptibility in this cohort.
Anatomically Based Strategies to Prevent Abducens Nerve Injuries in the Retrosigmoid Route: Insights from a Cadaveric Analysis
Leonel, Luciano, Graepel, Steven, Link, Michael J., Celda, María Peris, Torregrossa, Fábio , Piazza, Amedeo , Shinya, Yuki , Graepel, Steve, Grasso, Giovanni , Lanzino, Giuseppe

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 7, 2025 | Volume: 86 | Issue: No issue available | Pages: No page available

10.1055/s-0045-1803111 Get It

Elevated lipoprotein(a) levels linked to new-onset atrial fibrillation: insights from a retrospective cohort study
Kamel, Moaz, Mahmoud, Ahmed , Badr, Amro , Pereyra, Milagros , Scalia, Isabel G. , Ali, Nima Baba , Alsidawi, Said , Lester, Steven J., Rmilah, Anan Abu, Barry, Timothy, Shen, Win K., Scott, Luis R. , Masry, Hicham El , Valverde, Arturo M. , Sorajja, Dan , Ayoub, Chadi , Arsanjani, Reza , Mahmoud, Ahmed K , Pereyra Pietri, Milagros, Alsidawi, Said , Sardana, Mayank , Sorajja, Dan , Ayoub, Chadi , Arsanjani, Reza , El Masry, Hicham , Pereyra, Milagros , Scalia, Isabel G , Awad, Kamal , Farina, Juan M. , Abbas, Mohammed Tiseer , Rmilah, Anan Abu , Srivathsan, Komandoor

Mayo Clinic

European Journal of Preventive Cardiology | February 7, 2025 | Volume: 32 | Issue: 9 | Pages: 769-777

10.1093/eurjpc/zwaf063 | PMID 39919039 Get It

Abstract Aims Atrial fibrillation (AF) is the most common cardiac arrhythmia. Although lipoprotein(a) [Lp(a)] is known to be a well-established risk factor for atherosclerotic cardiovascular disease, its role in the development of AF, independent of this association, remains unclear. Methods and results Adult patients from the three Mayo Clinic sites with a baseline Lp(a) and without AF history were included. Patients were categorized into two groups based on their Lp(a) levels: high Lp(a) (≥50 mg/dL) and low Lp(a) (<50 mg/dL). Survival probabilities free from incident AF were compared between Lp(a) groups, during a follow-up period up to 15 years, using the Kaplan–Meier curve and the log-rank test. Multivariable Cox regression analysis was also conducted. A total of 75 376 patients were included (median age: 55 years, 59% males), with a median follow-up duration of 8.8 (inter-quartile range: 3.4, 14.8) years. Incident AF was detected in 5738 (7.6%) patients. Survival probability free from incident AF was significantly lower in patients with elevated Lp(a) (86%) compared with those with low Lp(a) (88%, log-rank P < 0.001). Multivariable analysis adjusted for potential risk factors of AF showed a statistically significant association of elevated Lp(a) with an 11% increase in AF risk (adjusted hazard ratio: 1.11, 95% confidence interval: 1.05–1.18). Conclusion Our study suggests that elevated Lp(a) (≥50 mg/dL) is an independent risk factor for incident AF. Future prospective studies are warranted to validate our results and to test if reducing Lp(a) could mitigate the burden of AF.
Association Between Autograft Choice and Psychological Readiness to Return to Sport After ACL Reconstruction
Brinkman, Joseph C. , Tummala, Sailesh V. , Richman, Evan H. , Haglin, Jack M. , Makovicka, Justin L. , Poon, Steven K. , Tummala, Sailesh V , Economopoulos, Kostas J. , Hassebrock, Jeffrey D.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | January 29, 2025 | Volume: 13 | Issue: 1 | Pages: No page available

10.1177/23259671241291926 | PMID 39877422 Get It

Background: It has been demonstrated that an athlete’s psychological readiness contributes to one’s ability to successfully return to sport (RTS) after anterior cruciate ligament (ACL) reconstruction. However, the effect of graft choice on psychological readiness is not yet understood. Purpose/Hypothesis: The purpose of this study was to evaluate the association between graft choice and an athlete’s psychological readiness to RTS. It was hypothesized that similar ACL-Return to Sport after Injury (ACL-RSI) scores would be achieved among patients who underwent ACL reconstruction with quadriceps autograft (QA), hamstring tendon autograft (HA), and bone–patellar tendon–bone (BTB) autograft. Study Design: Cohort study; Level of evidence, 3. Methods: Patients who underwent primary ACL reconstruction at a single institution between January 2017 and December 2018 were placed into separate cohorts depending on graft type (HA, BTB, or QA; n = 30 patients in each group), and the ACL-RSI, International Knee Documentation Committee subjective form, and Lysholm scores were compared between the different graft cohorts at 6 months postoperatively, at RTS, and at 2 years postoperatively. Also, the rate of patients who achieved an ACL-RSI score of ≥65 (predictive of return to preinjury sport at 2 years postoperatively) was calculated, as was the RTS rate and time. Results: The QA group demonstrated significantly higher ACL-RSI scores than both the HA and BTB groups at 6 months postoperatively ( P < .0001) and RTS ( P = .011). The QA group also had a higher rate of achieving ≥65 on ACL-RSI than the other groups at 6 months postoperatively ( P = .002) and RTS ( P = .024). There was no significant difference in the RTS rate between the 3 groups, although the QA group demonstrated a significantly quicker return (QA, 8.1 months; BTB, 9.6 months; HA, 10.5 months; P < .001). Conclusion: Athletes undergoing primary ACL reconstruction with QA achieved a higher mean ACL-RSI score and more often achieved a score of ≥65 at the 6-month and RTS time points compared with the HA and BTB groups. QA may afford an advantage over other grafts in terms of improved psychological readiness to RTS.